BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Despite the exciting advancements and investments accelerating
  the development of mRNA therapies\, there is still limited regulatory gu
 idance. Moreover\, developing standardized and sensitive assays to assess
  quality and stability still remains a key challenge.\n\nThe mRNA Assay D
 evelopment Summit is the first and only meeting to address the specific t
 echnical challenges of analytical\, bioanalytical and potency assay devel
 opment\, it will allow the field to develop a set of best practices to ac
 celerate the movement of mRNA drugs through the clinic and to the patient
 s. This meeting will showcase critical expertise and the latest assays de
 veloped by key industry players.\n\nJoin 60+ industry experts\, including
  Moderna\, Sanofi\, Beam Therapeutics and more this December! Address key
  bottlenecks in the field and ensure your assay strategy is robust and re
 producible to achieve regulatory compliance\, therefore fast-tracking mRN
 A therapeutics and vaccines into the clinic and towards approval.\n
DTEND:20231207T160000
DTSTAMP:20260512T234700Z
DTSTART:20231206T080000
LOCATION:Embassy Suites by Hilton Boston at Logan Airport\, 207\, Porter S
 treet\, Boston\, Massachusetts\, 02128\,
SEQUENCE:0
SUMMARY:Despite the exciting advancements and investments accelerating the
  development of mRNA therapies\, there is still limited regulatory guidan
 ce. Moreo...
UID:81a898a5-0868-427c-bb96-585d58165e53
END:VEVENT
END:VCALENDAR